Caricamento...
Resistance to Selumetinib (AZD6244) in Colorectal Cancer Cell Lines is Mediated by p70S6K and RPS6 Activation()
Selumetinib (AZD6244, ARRY-142886) is a MEK1/2 inhibitor that has gained interest as an anti-tumour agent. We have determined the degree of sensitivity/resistance to Selumetinib in a panel of colorectal cancer cell lines using cell proliferation and soft agar assays. Sensitive cell lines underwent G...
Salvato in:
Autori principali: | , , , , , , , , , , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
Neoplasia Press
2014
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4212257/ https://ncbi.nlm.nih.gov/pubmed/25379021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.08.011 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|